Eli Lilly v. Teva: Generic Companies Infringe Under Akamai IV in Case of Divided Infringement
Biotechnology Law Report Apr 2017, Vol. 36, No. 2: 31-37.
Source: Biotechnology Law Report - Category: Medical Law Source Type: research
More News: Biotechnology | Medical Law